The antioxidant vitamin E modulates amyloid β-peptide-induced creatine kinase activity inhibition and increased protein oxidation: Implications for the free radical hypothesis of Alzheimer's disease

Neurochemical Research

Volumn 24, Issue 3, 1999, Pages 427-435

  Yatin, Servet M ^c   Aksenov, Michael ^a   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c NONE

Author keywords

Alzheimer's disease; Amyloid; Creatine kinase; Free radicals; Protein oxidation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; CREATINE KINASE; FREE RADICAL;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CELL DEATH; CELLS, CULTURED; CREATINE KINASE; ELECTRON SPIN RESONANCE SPECTROSCOPY; EMBRYO; FREE RADICALS; HIPPOCAMPUS; NERVE TISSUE PROTEINS; NEURONS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; VITAMIN E;

ANIMALIA; LETHRINIDAE;

EID: 0032936688     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020997903147     Document Type: Article

References (56)

1. Katzman, R. and Saitoh, T. 1991. Advances in Alzheimer's disease. FASEB J. 4:278-286.
2. Selkoe, D. J. 1991 The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
3. Glenner, G. G., and Wong, C. W. 1984. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebravascular amyloid protein. Biochem. Biophys. Res. Commun. 120:885-890.
4. Selkoe, D. J. 1996 Amyloidß-protein and genetics of Alzheimer's disease. J. Biol. Chem. 271:18295-18298.
5. Behl, C., Davis, J., Cole, G. M., and Shubert, D. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186:944-950.
6. 2+ homeostasis Alzheimer's disease. Trends Neurosci. 16:409-414.
7. Harris, M., Hensley, K., Butterfield, D. A., Leedle, R. A., and Carney, J. M. 1995. Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta-peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131:193-202.
8. Mattson, M. P., Mark, R. J., Furukawa, K., and Bruce, A. J. 1997. Disruption of brain cell ion homeostasis in Alzheimer's disease by oxyradicals, and signaling pathways that protect therefrom. Chem Res. Toxicol. 10:507-517.
9. Butterfield, D. A., Hensley, K., Harris, M., Mattson, M., and Carney, J. M. 1994. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:710-715.
10. Koppal, T., Subramaniam, R., Drake, J., Prasad, M. R. and Butterfield, D. A. 1998. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 786:270-273.
11. Bruce-Keller, A. J., Begley, J. G., Fu, W., Butterfield, D. A., Bredesen, D. E., Hutchins, J. B., Hensley, K., and Mattson, M. P. 1998. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J. Neurochem. 70:31-39.
12. Subramaniam, R., Koppal, T., Green, M., Yatin, S., Jordan, B., Drake, J., and Butterfield, D. A. 1998. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: Relevance to the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 23:1403-1410.
13. Refelo, L. M., Wittenberg, I., Friedrich, V. L. Jr., and Robakis, N. K. 1991. The Alzheimer amyloid precursor is associated with the detergent-insoluble cytoskeleton. J. Neurosci. 11:3888-3897.
14. Yankner, B. A., Duffy, L. K., and Kirschnier, D. A. 1990. Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by Tachykinin neuropeptides. Science 250:279-282.
15. Aksenov, M. Y., Aksenova, M. V., Carney, J. M., and Butterfield, D. A. 1997. Oxidative modification of glutamine synthetase by amyloid β-peptide. Free Radic. Res. 27:267-281.
16. Butterfield, D. A. 1997. β-amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem. Res. Toxicol. 10:495-506.
17. Chauhan, A., Chauhan, V. P., Brockerhoff, H., and Wisniewski, H. M. 1991. Action of amyloid beta-protein on protein kinase C activity. Life Sci. 49:1555-1562.
18. Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., and Floyd, R. A. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc. Natl. Acad. Sci. USA 88:10540-10543.
19. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M. V., Harris, M. E., Wu; J. F., Floyd, R. A., and Butterfield, D. A. 1994. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-3274.
20. Wallace, M. A. 1994. Effects of Alzheimer's disease-related beta amyloid protein fragments on enzyme metabolizing, phosphoinositides in brain. Biochim. Biophys. Acta 1227:183-187.
21. Behl, C., Davis, J. B., Lesley, R., and Schubert, D. 1994. Hydrogen peroxide mediates amyloid βprotein toxicity. Cell 77:817-827.
22. Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., and Kimura, H. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92: 1989-1993.
23. Bessman, S. P. and Carpenter, C. L. 1985. The creatine-creatine phosphate energy shuttle. Annu. Rev. Biochem. 54:831-862.
24. McCord, J. M. and Russell, W. J. 1988. Inactivation of creatine phosphokinase by superoxide during reperfusion injury. Pages 869-873, in Simic, K. A., Word, J. F., and Von Sonntag, C. (eds.) Oxygen Radicals in Biology and Medicine, Plenum Press New York.
25. Suzuki, Y. J., Edmondson, J. D. and Ford, G. D. 1992. Inactivation of rabbit muscle creatine kinase by hydrogen peroxide. Free Radic. Res. Commun. 16:131-136.
26. Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenova, M., Aksenov, M., Gabbita, P., Carney, J., Markesberry, W., and Butterfield, D. A. 1995. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:2146-2156.
27. Balazs, L. and Leon, M. 1994. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1131-1137.
28. Markesbery, W. R., Lovell, M. A., and Ehmann, W. D. 1994. Increased lipid peroxidation and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurobiol. Aging. 15:S139-S140.
29. Markesbery, W. R. 1997. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:134-147.
30. Lovell, M. A., Ehmann, W. D., Buttler, S. M., and Markesbery, W. R. 1995. Elevated thiobarbituric acid-reactive substances and antioxidant activity in the brain in Alzheimer's disease. Neurology 45:1594-1601.
31. Lovell, M. A., Ehmann, W. D., Mattson, M. P., and Markesbery, W. R. 1997. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18:457-461.
32. Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., and Butterfield, D. A. 1997. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters conformation of cortical synaptosomal membrane products. J. Neurochem. 69: 1161-1169.
33. Bruce, A. J., Malfroy, B., and Baudry, M. 1996. β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA 93:2312-2316.
34. 2+-homeostasis and cell death. J. Neurosci. 15:6239-6249.
35. 2+ channels: A possible involvement of free radicals. J. Neurochem. 68:265-271.
36. Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., Schneider, L. S., Thal, L. J. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The New England J. Medicine 336:1216-1223.
37. Lockhart, B. P., Benicourt, C., Junien, J. L., and Privat, A. 1994. Inhibitors of free radical formation fail to attenuate direct β-amyloid 25-35 peptide mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39:494-505.
38. Pike, C. J., Ramezan-Arab, N., Cotman, C. W. 1997. β-amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants. J. Neurochem. 69:1601-1611.
39. Levine, R. L., Williams, J. A., Stadtman, E. R., and Shacter, E. 1994. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:346-357.
40. Laemmli, U. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
41. Glenney, J. R. 1986. Antibody probing on Western blots have been stained with India ink. Anal. Biochem. 156:315-318.
42. LeBel, C. P., Ischiropoulus, H. and Bondy, S. C. 1992. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5:227-231.
43. Bush A. I., Huang X., Atwood C. S., Cherny R. A., Moir R. D., Goldstein L. E., O'Malley C. M., Saunders A. J., Multhaup G., Beyreuther K., Masters C. L., and Tanzi R. E. 1998. Interactions with ionic zinc, copper and iron govern Aβ redox activity and accumulation in Alzheimer's disease. Neurobiol. Aging 19:S40.
44. Butterfield D. A., Varadarajan S., Lafontaine M., Subramaniam R., Koppal T., Yatin S., Hensley K., Aksenova M., and Aksenov M. 1998. Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. Neurobiol. Aging 19:S262.
45. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., and Cotman, C. W. 1995. Structure-activity analysis of β-amyloid peptides: contributions of the Aβ(25-35) region to aggregation and neurotoxicity. J. Neurochem. 64:253-265.
46. Aksenov, M. Y., Aksenova, M. V., Harris, M. E., Hensley, K., Butterfield, D. A., and Carney, J. M. 1995. Enhancement of Aβ(1-40) neurotoxicity by glutamine synthetase. J. Neurochem. 65: 1899-1902.
47. Oliver, C. N., Ahn, B. W., Moerman, E. J., Goldstein, S. and Stadtman, E. R. 1987. Age-related changes in oxidized proteins. J. Biol. Chem. 262:5488-5491.
48. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M., Floyd R. A. 1990. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA 87:5144-5147.
49. Butterfield, D. A. and Stadtman, E. R. 1997. Protein oxidation process in aging brain. Pages 161-191, in Mattson, M. P., and Geddes, J. W. (eds.), The Aging Brain, JAI Press, Greenwich, CT.
50. Stadtman E. R. and Berlett B. S. 1997. Reactive oxygen-mediated protein oxidation in aging and disease. Chem. Res. Toxicol. 10: 485-494.
51. Shacter, E., Williams, J. A., Lim, M., and Levine, R. L. 1994. Differential susceptibility of plasma proteins to oxidative modifications: examination by Western blot immunoassay. Free Rad. Biol. Med. 17:429-437.
52. Huang, X., Atwood, C. S., Goldstein, L. E., Hartshorn, M. A., Moir, R. D., Multhaup, G., Tanzi, R. E., and Bush, A. I. 1997. Alzheimer Aβ peptides simultaneously reduce metals and produce reactive oxygen species. Neuroscience Abstr. 23:1663.
53. Tomiyama, T., Shaji, A., Kataoka, K., Suwa, Y., Asano, S., Kaneko, H., and Endo, N. 1996. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxy radical scavenger. J. Biol. Chem. 271:6839-6844.
54. Morin, L. G. 1977. Creatine kinase: Stability, inactivation and reactivation. Clin Chem. 23:646-652.
55. Pettegrew, J. M., Panchalingam, K., Klunk, W. E., McClure, R. J., and Muenz, L. R. 1994. Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol. Aging 15:117-132.
56. Burmistrov, S. O., Mashek, O. P. and Kotin, A. M. 1992. The action of acute alcoholic intoxication on the antioxidant system and creatin kinase activity in the brain of rat embryos. Eksp. Klin. Farmakol. 55:54-56.